
FST-344 (Follistatin 344)
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
FST-344 (Follistatin 344) is a naturally occurring glycoprotein that binds and neutralizes members of the TGF-β superfamily, most importantly myostatin and activin. By sequestering these negative regulators, it is a key research tool for studying muscle-growth control.
| Test | Result | Status |
|---|---|---|
| Purity | 99.8% | Passed ✓ |
Research Information
FST-344 is studied for its antagonism of myostatin and activin signaling and the resulting influence on muscle-cell proliferation and differentiation in models of muscle biology. Research examines how neutralizing these growth inhibitors affects muscle mass and regeneration. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
FST-344 (Follistatin 344) Research & Studies
What is FST-344 (Follistatin 344)?
FST-344 (Follistatin 344) is a naturally occurring glycoprotein isoform examined in laboratory research for its ability to bind and neutralize selected members of the TGF-β superfamily. Investigators focus on its interactions with myostatin and activin as a means to probe negative regulation of muscle-cell pathways. The compound serves as a research tool in cellular and molecular model systems that explore growth-factor sequestration. It is supplied strictly for in-vitro and laboratory research use only.
Mechanism of Action
In experimental systems, FST-344 binds myostatin and activin with high affinity, sequestering these ligands and preventing receptor engagement. This action interrupts Smad-dependent signaling cascades that ordinarily limit myoblast proliferation and differentiation. Laboratory studies track consequent changes in gene-expression patterns linked to muscle-cell development. Such work clarifies how neutralization of these inhibitors reshapes intracellular control of muscle biology pathways.
Primary Areas of Research
Research on FST-344 centers on muscle biology models that evaluate antagonism of myostatin and activin signaling. Investigators examine effects on muscle-cell proliferation, differentiation, and regenerative responses within controlled culture environments. Additional studies address broader TGF-β superfamily dynamics and related cellular outcomes. All investigations remain confined to in-vitro assays and non-clinical experimental platforms.
Key Research Findings
Cellular studies have shown that FST-344 can sequester myostatin, resulting in measurable shifts in myoblast activity under laboratory conditions. Parallel work documents altered differentiation markers when activin signaling is blocked by the glycoprotein. Findings consistently support its value as a tool for dissecting negative regulators of muscle mass in model systems. Observations derive exclusively from molecular and cell-based assays.
Research Handling and Considerations
FST-344 is designated solely for laboratory research and should be handled according to standard recombinant-protein protocols. Its glycoprotein character requires attention when designing binding assays or cell-culture experiments involving TGF-β family ligands. Appropriate storage and reconstitution practices help preserve functional activity in experimental setups. Use is restricted to in-vitro investigations within controlled research environments.
Frequently Asked Questions
Laboratory work focuses on its neutralization of myostatin and activin within the TGF-β superfamily, thereby modulating Smad-mediated cascades that regulate muscle-cell proliferation and differentiation.
Explore Other High-Purity Peptides

Ipamorelin

CJC-1295 (No DAC)

Sermorelin
